神经病学与神经康复学杂志2025，Vol.21Issue(3)：147-157,11.DOI:10.12022/jnnr.2025-0041
《脑淀粉样血管病的波士顿标准2.0》解读
Comments on Boston criteria version 2.0 for cerebral amyloid angiopathy
摘要
Abstract
In 2022,the International Cerebral Amyloid Angiopathy Association published the Boston criteria version 2.0 for cerebral amyloid angiopathy:a multicentre,retrospective,MRI-neuropathology diagnostic accuracy study.This updated version has made significant revisions,including lowering the minimum age for diagnosing cerebral amyloid angiopathy,adding symptoms such as convexal subarachnoid hemorrhage,transient focal neurological episodes,and cognitive impairment/dementia,and incorporating multiple hemorrhagic and non-hemorrhagic imaging biomarkers.Compared with previous diagnostic versions,this latest version of the criteria demonstrates significantly improved diagnostic sensitivity,particularly in patients with symptomatic intracerebral hemorrhage.Therefore,this paper aims to summarize the Boston criteria version 2.0 for cerebral amyloid angiopathy with evidence from China Brain Bank and the clinical practice experience of our team as references for domestic peers.关键词
脑淀粉样血管病/波士顿标准/诊断标准/影像学标志物Key words
Cerebral amyloid angiopathy/Boston criteria/Diagnostic criteria/Imaging marker引用本文复制引用
李爽,杜鹃,宋雅颖,王刚..《脑淀粉样血管病的波士顿标准2.0》解读[J].神经病学与神经康复学杂志,2025,21(3):147-157,11.基金项目
科技创新2030重大项目"脑科学与类脑研究"(2021ZD0201804) Science and Technology Innovation 2030 Major Project:Neuroscience and Brain-like Research(2021ZD0201804) （2021ZD0201804）
